1-8 of 8
Michael Rytting, M.D.
Close
Sort by
Journal Articles

A Phase 1 Study of Dose-Dense 5-Aza-2′-Deoxycitidine (decitabine) in Relapse Refractory Acute Lymphocytic Leukemia (ALL).

Guillermo Garcia-Manero, MD, Deborah Thomas, Michael Rytting, M.D., Patrick A. Zweidler-McKay, MD/PhD, Hui Yang, MD, PhD, Zhihong Fang, Shaoqing Kuang, PhD, Samuel Dara, Susan O'Brien, M.D., Hagop M. Kantarjian, MD
Journal: Blood
Blood (2009) 114 (22): 2030.
https://doi.org/10.1182/blood.V114.22.2030.2030
Published: 2009
Journal Articles

Pediatric-Based Therapy for Young Adults with Newly Diagnosed Lymphoblastic Leukemia.

Michael Rytting, M.D., Deborah A. Thomas, MD, Anna R Franklin, Elias Jabbour, William Wierda, MD, PhD, Stefan Faderl, MD, Robert Wells, MD, Tapan Kadia, MD, Farhad Ravandi, M.D., Alessandra Ferrajoli, MD., Jorge Cortes, MD, Susan O'Brien, Hagop Kantarjian, MD
Journal: Blood
Blood (2009) 114 (22): 2037.
https://doi.org/10.1182/blood.V114.22.2037.2037
Published: 2009
Journal Articles

Outcome for Adolescents and Young Adults (AYA) with the Hyper-CVAD (with or without Rituximab) Regimens for De Novo Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma.

Deborah A. Thomas, MD, Michael Rytting, M.D., Susan O'Brien, MD, Stefan Faderl, MD, William G. Wierda, MD, PhD, Anna Franklin, MD, Rebecca Garris, Farhad Ravandi, MD, Jorge Cortes, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2009) 114 (22): 3084.
https://doi.org/10.1182/blood.V114.22.3084.3084
Published: 2009
Journal Articles

Experience with the Combination of a Hypomethylating Agent and Valproic Acid in Pediatric Acute Myelogenous Leukemia

Michael Rytting, M.D., Patrick Zweidler-McKay, M.D., Ph.D., Yang Hui, Hagop Kantarjian, M.D., Guillermo Garcia-Manero, M.D.
Journal: Blood
Blood (2008) 112 (11): 4036.
https://doi.org/10.1182/blood.V112.11.4036.4036
Published: 2008
Journal Articles

Young Adults with Acute Lymphoblastic Leukemia (ALL) Treated with Adapted Augmented Berlin-Frankfurt-Munster (ABFM) Therapy

Michael Rytting, M.D., Deborah Thomas, M.D., Anna Franklin, M.D., William Wierda, M.D., Stefan Faderl, M.D., Farhad Ravandi, M.D., Brenda Muriera, RN, Hagop M. Kantarjian, MD, Susan O’Brien, M.D.
Journal: Blood
Blood (2008) 112 (11): 3957.
https://doi.org/10.1182/blood.V112.11.3957.3957
Published: 2008
Journal Articles

Toxicities in Adults with Acute Lymphoblastic Leukemia (ALL) Treated with Regimens Using Pegasparaginase.

Michael Rytting, M.D., Marc Earl, PharmD, Dan Douer, MD, Brenda Muriera, RN, Anjali Advani, MD, Archie Bleyer, MD
Journal: Blood
Blood (2008) 112 (11): 1924.
https://doi.org/10.1182/blood.V112.11.1924.1924
Published: 2008
Journal Articles

Durable Remissions Observed in a Phase I/II Study of Clofarabine in Combination with Etoposide and Cyclophosphamide in Pediatric Patients with Refractory or Relapsed Acute Leukemia

Nobuko Hijiya, MD, Paul S. Gaynon, MD, Manuel Fernandez, Lewis B. Silverman, MD, Blythe Thomson, MD, Roland Chu, Todd Cooper, DO, Richard Kadota, MD, Michael Rytting, M.D., Peter G. Steinherz, MD, Violet Shen, Sima Jeha, MD, Elly Barry, MD, William L. Carroll, MD
Journal: Blood
Blood (2008) 112 (11): 2925.
https://doi.org/10.1182/blood.V112.11.2925.2925
Published: 2008
Journal Articles

Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL) after Frontline Therapy with Hyper-CVAD Regimens.

Deborah A. Thomas, MD, Susan O’Brien, M.D., Michael Rytting, M.D., Stefan Faderl, MD, Jorge Cortes, MD, William G. Wierda, MD, PhD, Farhad Ravandi, MBBS, Hagop M Kantarjian
Journal: Blood
Blood (2008) 112 (11): 1930.
https://doi.org/10.1182/blood.V112.11.1930.1930
Published: 2008